Liposomal adjuvant development for leishmaniasis vaccines.

about

Liposomal adjuvant development for leishmaniasis vaccines.

Item

http://www.wikidata.org/entity/Q47153161

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Liposomal adjuvant development for leishmaniasis vaccines.

@en

Liposomal adjuvant development for leishmaniasis vaccines.

@nl

type

Item

label

Liposomal adjuvant development for leishmaniasis vaccines.

@en

Liposomal adjuvant development for leishmaniasis vaccines.

@nl

prefLabel

Liposomal adjuvant development for leishmaniasis vaccines.

@en

Liposomal adjuvant development for leishmaniasis vaccines.

@nl

P1476

Liposomal adjuvant development for leishmaniasis vaccines.

@en

P2093

Ali Badiee

http://www.w3.org/2001/XMLSchema#string

Ali Khamesipour

http://www.w3.org/2001/XMLSchema#string

Anis Askarizadeh

http://www.w3.org/2001/XMLSchema#string

Mahmoud Reza Jaafari

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting dendritic cells: a promising strategy to improve vaccine effectiveness

Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies

Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators

Potentiating effects of MPL on DSPC bearing cationic liposomes promote recombinant GP63 vaccine efficacy: high immunogenicity and protection

Vaccines for the leishmaniases: proposals for a research agenda

Drug resistance in leishmaniasis

Identification of novel Leishmania donovani antigens that help define correlates of vaccine-mediated protection in visceral leishmaniasis

Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis.

Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells. mangala.rao@na.amedd.army.mil.

Lipophosphoglycan of Leishmania major that vaccinates against cutaneous leishmaniasis contains an alkylglycerophosphoinositol lipid anchor

P304

85-101

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1177/2051013617741578

http://www.w3.org/2001/XMLSchema#string

P433

4-5

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29201374

http://www.w3.org/2001/XMLSchema#string

P932

5697592

http://www.w3.org/2001/XMLSchema#string